Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 0.35 |
| ▸ | CA2 | P00918 | 7/20 | 0.35 |
| ▸ | CA9 | Q16790 | 7/20 | 0.35 |
| ▸ | CA12 | O43570 | 5/20 | 0.35 |
| ▸ | CA7 | P43166 | 4/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.34 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14805176 | 0.79 | CA12 (0.54) | CA1CA2CA9CA12CA7 | |
| SCHEMBL19874548 | 0.78 | CTRC (0.41) | CA1CA2CA9CA12CA7 | |
| SCHEMBL19891667 | 0.78 | CA1 (0.38) | CA1CA2CA9CA12CA7 | |
| SCHEMBL19874475 | 0.76 | CA12 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL19874527 | 0.76 | CA12 (0.44) | CA1CA2CA9CA12CA7 | |
| SCHEMBL14805173 | 0.76 | CA1 (0.35) | CA1CA2CA9CA12CA7 | |
| SCHEMBL19891716 | 0.76 | CA1 (0.59) | CA1CA2CA9CA12CA7 | |
| SCHEMBL19887232 | 0.75 | CA1 (0.39) | CA1CA2CA9CA12CA7 | |
| SCHEMBL1683275 | 0.74 | F2 (0.54) | CA1CA2CA9CA12MMP2 | |
| SCHEMBL26812 | 0.73 | HTT (0.47) | CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10385016-B2 | Non explosive bis-sulfonyl azides | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) | 2019-08-20 | — | — | US | disclosed |
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK (DE) | 2018-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10385016-B2 | Non explosive bis-sulfonyl azides | ARSA, MSRB3, NES | CA1 2823/4885CA2 1475/4885CA9 2023/4885 |
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | ARSA, MSRB3, NES | CA1 2828/4885CA2 1444/4885CA9 1954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.